APA (7th ed.) Citation

J, C., AM, P., V, A., SA, S., K, N., IM, D., . . . N, W. (2022). Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma. Genome medicine, 14(1), 58. https://doi.org/10.1186/s13073-022-01060-8

Chicago Style (17th ed.) Citation

J, Creaney, et al. "Comprehensive Genomic and Tumour Immune Profiling Reveals Potential Therapeutic Targets in Malignant Pleural Mesothelioma." Genome Medicine 14, no. 1 (2022): 58. https://doi.org/10.1186/s13073-022-01060-8.

MLA (9th ed.) Citation

J, Creaney, et al. "Comprehensive Genomic and Tumour Immune Profiling Reveals Potential Therapeutic Targets in Malignant Pleural Mesothelioma." Genome Medicine, vol. 14, no. 1, 2022, p. 58, https://doi.org/10.1186/s13073-022-01060-8.